Ranbaxy, Schwarz Pharma deal

Ranbaxy received a $4 million milestone from Schwarz under a 2002 development and marketing deal for RBx-2258, which Ranbaxy licensed to Schwarz (see BioCentury, July 1, 2002). The payment was trigger...